Zacks Investment Research on MSN

Is trending stock Pfizer Inc. (PFE) a buy now?

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Here’s Why Pfizer (PFE) Is One of the Most Undervalued US Stocks

Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued US Stocks According to Hedge Funds. On May 13, Pfizer Inc.

Pfizer advances pneumonia shot after getting positive results in children

Pfizer Inc. said a new version of its bestselling Prevnar vaccine may provide infants with better protection against common ...
American Association of Individual Investors

Is Pfizer Inc. (PFE) Stock a Good Investment?

Learn more about Pfizer Inc.'s (PFE) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether ...
The Caledonian-Record

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Pfizer Inc. (NYSE: PFE) today announced data from its Phase 2 study ( NCT06524414) evaluating the safety, tolerability and immunogenicity of a four-dose series of its investigational 25-valent ...

Wolfe Research Says COVID Uncertainty Continues to Weigh on Pfizer (PFE) Outlook

With an annual dividend yield of 6.68%, Pfizer Inc. (NYSE:PFE) is included among the 10 Best Dividend Stocks with 5%+ Yields ...

Here is Why Pfizer (PFE) One of the Best High Volume Stocks to Invest In

Pfizer Inc. (NYSE:PFE) is one of the best high volume stocks to invest in according to hedge funds. On May 5, Pfizer reported ...

FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer

Why Johnson & Johnson’s stability, dividend growth, and buybacks may beat Pfizer’s low valuation and high yield. Read the ...

Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend

It looks like Pfizer Inc. ( NYSE:PFE ) is about to go ex-dividend in the next three days. The ex-dividend date is ...

Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds Pfizer Inc.
Las Vegas Sun

European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

(NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization to expand the approved indication for HYMPAVZI ® (marstacimab) to include patients 12 years of age and ...